J. Walden

933 total citations
27 papers, 508 citations indexed

About

J. Walden is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. Walden has authored 27 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. Walden's work include Bipolar Disorder and Treatment (16 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). J. Walden is often cited by papers focused on Bipolar Disorder and Treatment (16 papers), Epilepsy research and treatment (8 papers) and Pharmacological Effects and Toxicity Studies (8 papers). J. Walden collaborates with scholars based in Germany and United States. J. Walden's co-authors include Heinz Grunze, Claus Normann, Dawn Dhavale, Ralph Kupka, Kirk D. Denicoff, Trisha Suppes, Lori L. Altshuler, Gabriele S. Leverich, Robert M. Post and Willem A. Nolen and has published in prestigious journals such as Schizophrenia Research, The Journal of Clinical Psychiatry and Journal of Psychiatric Research.

In The Last Decade

J. Walden

27 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Walden Germany 9 404 86 73 49 49 27 508
A. J. Mander United Kingdom 13 349 0.9× 76 0.9× 65 0.9× 73 1.5× 21 0.4× 32 543
Carla Conroy United States 14 404 1.0× 115 1.3× 36 0.5× 111 2.3× 48 1.0× 30 624
Per Vendsborg Denmark 12 249 0.6× 79 0.9× 30 0.4× 37 0.8× 51 1.0× 33 509
KN Roy Chengappa United States 7 609 1.5× 152 1.8× 67 0.9× 98 2.0× 20 0.4× 7 694
Dean Elbe Canada 10 250 0.6× 105 1.2× 86 1.2× 73 1.5× 28 0.6× 35 414
Stavros Tourkodimitris United States 10 463 1.1× 140 1.6× 80 1.1× 104 2.1× 52 1.1× 28 639
Colin O’Donnell Australia 12 355 0.9× 199 2.3× 42 0.6× 41 0.8× 28 0.6× 13 605
M.T. Abou‐Saleh United Kingdom 12 273 0.7× 145 1.7× 41 0.6× 157 3.2× 36 0.7× 17 565
Douglas Vanderburg United States 11 336 0.8× 138 1.6× 64 0.9× 105 2.1× 37 0.8× 19 534
Joseph K. Stanilla United States 11 388 1.0× 106 1.2× 25 0.3× 65 1.3× 191 3.9× 23 703

Countries citing papers authored by J. Walden

Since Specialization
Citations

This map shows the geographic impact of J. Walden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Walden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Walden more than expected).

Fields of papers citing papers by J. Walden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Walden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Walden. The network helps show where J. Walden may publish in the future.

Co-authorship network of co-authors of J. Walden

This figure shows the co-authorship network connecting the top 25 collaborators of J. Walden. A scholar is included among the top collaborators of J. Walden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Walden. J. Walden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rm, Post, L. Altshuler, Willem A. Nolen, et al.. (2004). Switch rate on venlafaxine compared with bupropion and sertraline. Data Archiving and Networked Services (DANS). 2 indexed citations
2.
Frey, Simon, et al.. (2002). Electronic Diary for Bipolar Patients. Neuropsychobiology. 46(Suppl. 1). 10–12. 16 indexed citations
3.
McElroy, Susan L., Mark A. Frye, Trisha Suppes, et al.. (2002). Correlates of Overweight and Obesity in 644 Patients With Bipolar Disorder. The Journal of Clinical Psychiatry. 63(3). 207–213. 271 indexed citations
4.
Grunze, Heinz, Benedikt L. Amann, Sandra Dittmann, & J. Walden. (2002). Clinical Relevance and Treatment Possibilities of Bipolar Rapid Cycling. Neuropsychobiology. 45(Suppl. 1). 20–26. 8 indexed citations
5.
Valerius, Gabi, et al.. (2002). Life charts on a palmtop computer: first results of a feasibility study with an electronic diary for bipolar patients. Bipolar Disorders. 4(s1). 107–108. 32 indexed citations
6.
Heßlinger, Bernd, J. Walden, & Claus Normann. (2001). Acute and Long-Term Treatment of Catatonia with Risperidone. Pharmacopsychiatry. 34(1). 25–26. 25 indexed citations
7.
Grunze, Heinz, et al.. (2000). Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen. Fortschritte der Neurologie · Psychiatrie. 68(11). 496–502. 2 indexed citations
8.
Amann, Benedikt L., et al.. (2000). Bupropion-induced isolated impairment of sensory trigeminal nerve function. International Clinical Psychopharmacology. 15(2). 115–116. 4 indexed citations
9.
Langosch, Jens M., Xiaoyan Zhou, Heinz Grunze, & J. Walden. (2000). New Insights into the Mechanisms and Sites of Action of Lamotrigine. Neuropsychobiology. 42(Suppl. 1). 26–27. 2 indexed citations
10.
Grunze, Heinz, et al.. (2000). Modulation of Neural Cell Membrane Conductance by the Herbal Anxiolytic and Antiepileptic Drug Aswal. Neuropsychobiology. 42(Suppl. 1). 28–32. 7 indexed citations
11.
Walden, J., Claus Normann, Jens M. Langosch, & Heinz Grunze. (1999). Wirksamkeitsprädiktoren für Phasenprophylaktika (Stimmungsstabilisierer) bei bipolaren affektiven Störungen. Fortschritte der Neurologie · Psychiatrie. 67(2). 75–80. 3 indexed citations
12.
Brandt, Christian, Heinz Grunze, Claus Normann, & J. Walden. (1998). Acetazolamide in the Treatment of Acute Mania. Neuropsychobiology. 38(3). 202–203. 9 indexed citations
13.
Grunze, Heinz, et al.. (1998). Lack of antimanic efficacy of the GABA transporter 1 inhibitor tiagabine. European Neuropsychopharmacology. 8. S195–S195. 2 indexed citations
14.
Erfurth, Andreas, et al.. (1998). An open label study of gabapentin in the treatment of acute mania. Journal of Psychiatric Research. 32(5). 261–264. 56 indexed citations
15.
Normann, Claus, Bernd Heßlinger, Jan Bauer, Thomas Berger, & J. Walden. (1998). Die Bedeutung des hepatischen Cytochrom-P450-Systems für die Psychopharmakologie. Der Nervenarzt. 69(11). 944–955. 6 indexed citations
16.
Langosch, Jens M. & J. Walden. (1998). Bedeutung kalziumantagonistischer Effekte für die medikamentöse Therapie affektiver Störungen*. Fortschritte der Neurologie · Psychiatrie. 66(12). 570–579. 1 indexed citations
17.
Walden, J., Claus Normann, Jens M. Langosch, Thomas Berger, & Heinz Grunze. (1998). Differential Treatment of Bipolar Disorder with Old and New Antiepileptic Drugs. Neuropsychobiology. 38(3). 181–184. 20 indexed citations
18.
Walden, J. & Bernd Heßlinger. (1995). Bedeutung alter und neuer Antiepileptika in der Behandlung psychischer Erkrankungen. Fortschritte der Neurologie · Psychiatrie. 63(8). 320–335. 7 indexed citations
19.
Fritze, J., et al.. (1994). Carbamazepine as Adjunct or Alternative to Lithiumin the Prophylaxis of Recurrent Affective Disorders. Pharmacopsychiatry. 27(5). 181–185. 6 indexed citations
20.
Walden, J., et al.. (1992). Bedeutung von Kalziumionen und Kalziumantagonisten bei affektiven Psychosen. Fortschritte der Neurologie · Psychiatrie. 60(12). 471–476. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. J. Mander Breakdown of academic impact, for papers by Carla Conroy Breakdown of academic impact, for papers by Per Vendsborg Breakdown of academic impact, for papers by KN Roy Chengappa Breakdown of academic impact, for papers by Dean Elbe Breakdown of academic impact, for papers by Stavros Tourkodimitris Breakdown of academic impact, for papers by Colin O’Donnell Breakdown of academic impact, for papers by M.T. Abou‐Saleh Breakdown of academic impact, for papers by Douglas Vanderburg Breakdown of academic impact, for papers by Joseph K. Stanilla
Rankless by CCL
2026